The aim of ReMedIA is to exploit the numerous biological (DNA, RNA, proteins, metabolites, …), clinical (imaging, functional assessments, …), environmental and psycho-social data that will be available in order to build predictive models based on Artificial Intelligence and to apply them to the development of better screening, better diagnoses and better treatment plans. This will also ensure that the patient is more effectively involved in the therapeutic choices thanks to the explicitness of the models. 

In order to effectively deploy this approach, the ReMedIA initiative will be constituted as a de facto association through a pact of understanding linking all the key players in the field in the Walloon Region, based on the tools that already exist (Biowin, Patient Numérique, Hospitals.be, etc.). A portfolio of 8 projects will cover the entire field. ReMedIA will thus constitute a hub of innovation allowing the translation of the best research results into clinical practice and the efficient organisation of data collected in hospitals but also through cohorts in Wallonia and the integration of these cohorts into major international initiatives.